Go Pro

Bryn Mawr Trust Advisors LLC Makes New Investment in Nutrien Ltd. $NTR

Nutrien logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Bryn Mawr Trust Advisors initiated a roughly $8.36 million position in Nutrien by purchasing 132,848 shares during the second quarter. Other institutional investors also increased their holdings, with institutions collectively owning 63.1% of the stock.
  • Analyst sentiment is broadly positive: Nutrien has a “Moderate Buy” consensus rating from MarketBeat, with 17 Buy, three Hold and one Sell rating, and an average price target of $81.58.
  • Nutrien reported quarterly revenue of $10.81 billion, up 3.6% year over year, though adjusted earnings of $2.61 per share missed estimates. The company declared a quarterly dividend of $0.55 per share, representing a 3.2% annualized yield.
  • MarketBeat previews the top five stocks to own by September 1st.

Bryn Mawr Trust Advisors LLC bought a new stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 132,848 shares of the company's stock, valued at approximately $8,363,000.

A number of other hedge funds have also recently modified their holdings of the business. TD Waterhouse Canada Inc. lifted its position in shares of Nutrien by 4.2% during the fourth quarter. TD Waterhouse Canada Inc. now owns 2,359,022 shares of the company's stock worth $145,257,000 after purchasing an additional 94,510 shares during the last quarter. Vanguard Group Inc. increased its stake in Nutrien by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company's stock worth $1,386,546,000 after buying an additional 479,834 shares during the period. Geode Capital Management LLC increased its stake in Nutrien by 6.8% in the 4th quarter. Geode Capital Management LLC now owns 4,833,284 shares of the company's stock worth $304,217,000 after buying an additional 309,025 shares during the period. Black Creek Investment Management Inc. lifted its holdings in Nutrien by 7.9% during the 4th quarter. Black Creek Investment Management Inc. now owns 2,553,108 shares of the company's stock valued at $157,796,000 after buying an additional 185,864 shares in the last quarter. Finally, Oxbow Advisors LLC lifted its holdings in Nutrien by 35.2% during the 4th quarter. Oxbow Advisors LLC now owns 142,981 shares of the company's stock valued at $8,825,000 after buying an additional 37,246 shares in the last quarter. Institutional investors own 63.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on NTR shares. UBS Group dropped their target price on shares of Nutrien from $67.00 to $65.00 and set a "sell" rating on the stock in a research note on Monday, May 11th. Weiss Ratings raised shares of Nutrien from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, August 6th. BNP Paribas Exane raised Nutrien from a "neutral" rating to an "outperform" rating and set a $80.00 price objective on the stock in a research note on Tuesday, July 28th. Canadian Imperial Bank of Commerce restated an "outperform" rating on shares of Nutrien in a report on Monday. Finally, Bank of America raised Nutrien from a "neutral" rating to a "buy" rating and set a $82.00 target price for the company in a research report on Thursday, April 30th. Seventeen investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $81.58.

View Our Latest Analysis on NTR

Nutrien Trading Up 1.2%

NYSE:NTR opened at $68.26 on Friday. Nutrien Ltd. has a one year low of $53.03 and a one year high of $85.36. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The firm has a market cap of $32.65 billion, a P/E ratio of 13.82, a P/E/G ratio of 0.67 and a beta of 0.61. The firm has a 50-day simple moving average of $65.93 and a 200-day simple moving average of $70.39.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The business had revenue of $10.81 billion during the quarter, compared to analysts' expectations of $10.44 billion. During the same period in the previous year, the company posted $2.65 EPS. Nutrien's revenue for the quarter was up 3.6% on a year-over-year basis. Equities analysts anticipate that Nutrien Ltd. will post 5.01 EPS for the current fiscal year.

Nutrien Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Shareholders of record on Tuesday, September 29th will be issued a dividend of $0.55 per share. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 dividend on an annualized basis and a yield of 3.2%. Nutrien's dividend payout ratio is currently 44.53%.

About Nutrien

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Read More

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines